NO934653L - Anvendelse av trombininhibitorer for inhibitering av okkular fibrindannelse - Google Patents

Anvendelse av trombininhibitorer for inhibitering av okkular fibrindannelse

Info

Publication number
NO934653L
NO934653L NO934653A NO934653A NO934653L NO 934653 L NO934653 L NO 934653L NO 934653 A NO934653 A NO 934653A NO 934653 A NO934653 A NO 934653A NO 934653 L NO934653 L NO 934653L
Authority
NO
Norway
Prior art keywords
inhibition
thrombin inhibitors
fibrin formation
ocular
ocular fibrin
Prior art date
Application number
NO934653A
Other languages
English (en)
Norwegian (no)
Inventor
Jurgen Romisch
Eric Paul Paques
Eckhard Schuler
Original Assignee
Behringswerke Aktiengelschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringswerke Aktiengelschaft filed Critical Behringswerke Aktiengelschaft
Publication of NO934653L publication Critical patent/NO934653L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A61K38/58—Protease inhibitors from animals; from humans from leeches, e.g. hirudin, eglin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO934653A 1992-12-17 1993-12-16 Anvendelse av trombininhibitorer for inhibitering av okkular fibrindannelse NO934653L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4242655A DE4242655A1 (de) 1992-12-17 1992-12-17 Verwendung von Thrombin-Inhibitoren zur Inhibition okularer Fibrinbildung

Publications (1)

Publication Number Publication Date
NO934653L true NO934653L (no) 1994-06-20

Family

ID=6475561

Family Applications (2)

Application Number Title Priority Date Filing Date
NO934653A NO934653L (no) 1992-12-17 1993-12-16 Anvendelse av trombininhibitorer for inhibitering av okkular fibrindannelse
NO934653D NO934653D0 (no) 1992-12-17 1993-12-16 Anvendelse av trombininhibitorer for inhibitering av okkular fibrindannelse

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO934653D NO934653D0 (no) 1992-12-17 1993-12-16 Anvendelse av trombininhibitorer for inhibitering av okkular fibrindannelse

Country Status (7)

Country Link
EP (1) EP0603112A1 (fr)
JP (1) JPH06228006A (fr)
KR (1) KR940013532A (fr)
AU (1) AU675090B2 (fr)
CA (1) CA2111644A1 (fr)
DE (1) DE4242655A1 (fr)
NO (2) NO934653L (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5510369A (en) * 1994-07-22 1996-04-23 Merck & Co., Inc. Pyrrolidine thrombin inhibitors
US5629324A (en) * 1995-04-10 1997-05-13 Merck & Co., Inc. Thrombin inhibitors
US5798377A (en) * 1996-10-21 1998-08-25 Merck & Co., Inc. Thrombin inhibitors
CA2404115A1 (fr) * 2000-03-20 2001-09-27 Knoll Gmbh Utilisation de peg-hirudine en tant qu'anticoagulant dans le traitement extracorporel du sang
WO2002050056A1 (fr) 2000-12-18 2002-06-27 Merck & Co., Inc. Derives de benzylamine et leur utilisation comme inhibiteurs de thrombine
US6528503B2 (en) 2000-12-18 2003-03-04 Merck & Co., Inc. Thrombin inhibitors
WO2002064559A2 (fr) 2001-02-09 2002-08-22 Merck & Co., Inc. Inhibiteurs de thrombine
US7084134B2 (en) 2002-05-02 2006-08-01 Merk & Co., Inc. Thrombin inhibitors

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8203887D0 (sv) * 1982-06-23 1982-06-23 Kabivitrum Ab Nya trombininhiberande foreningar
DE3445532A1 (de) * 1984-12-13 1986-06-19 Plantorgan Werk Heinrich G.E. Christensen, KG, 2903 Bad Zwischenahn Hirudin-pa, desulfatohirudine-pa, verfahren zur herstellung und pharmazeutische mittel, die diese wirkstoffe enthalten
GB8504025D0 (en) * 1985-02-16 1985-03-20 Biopharm Ltd Hyaluronidase
PT84170B (pt) * 1986-01-24 1989-03-30 Sanofi Sa Processo para a preparacao de derivados n alfa-substituidos das n alfa-aril-sulfonilaminoacil d-amidinofenil-alaninamidas
NL8902454A (nl) * 1989-10-03 1991-05-01 Stichting Centraal Lab Mutanten van de humane plasminogeen activator inhibitor 1 (pai-1), hun bereiding en toepassing, en recombinante polynucleotiden die voor deze mutanten coderende genetische informatie omvatten.
TW201303B (fr) * 1990-07-05 1993-03-01 Hoffmann La Roche
DE4111394A1 (de) * 1991-04-09 1992-10-15 Behringwerke Ag Amidinophenylalaninderivate, verfahren zu deren herstellung, deren verwendung und diese enthaltende mittel

Also Published As

Publication number Publication date
JPH06228006A (ja) 1994-08-16
KR940013532A (ko) 1994-07-15
AU5243693A (en) 1994-06-30
CA2111644A1 (fr) 1994-06-18
NO934653D0 (no) 1993-12-16
AU675090B2 (en) 1997-01-23
EP0603112A1 (fr) 1994-06-22
DE4242655A1 (de) 1994-06-23

Similar Documents

Publication Publication Date Title
MD1507G2 (ro) Inhibitori, compoziţie farmaceutică pe baza lor şi procedeu de inhibare a HIV proteazei
NO933239L (fr)
CA2080223A1 (fr) Thiophenesulfonamides qui sont utiles comme inhibiteurs de l'anhydrase carbonique
NO932620L (no) Amindiol-proteaseinhibitorer
WO1992012717A3 (fr) Composition contenant une tetracycline et utilisation pour inhiber l'angiogenese
AU4787496A (en) Coating for bio-material insertable into the bloodstream or tissue of the human body
CA2264901A1 (fr) Association inhibiteurs de no synthase et piegeurs des formes reactives de l'oxygene
SE9704870D0 (sv) New pharmaceutical formulation I
CA2186039A1 (fr) Nouvelle forme galenique pharmaceutique orale
MX9600857A (es) Forma de dosificacion i en tabletas, con unidades multiples.
YU63699A (sh) Preparati za tretiranje i prevenciju arterijske tromboze i korišćenje inhibitora faktora xa samog ili u kombinaciji sa plateletnim antiagregacionim agensom
ATE252885T1 (de) Plan zur verabreichung von h+, k+-atpase inhibitoren
IL139967A (en) Beta-alanine derivatives and pharmaceutical compositions containing the same
NO934653L (no) Anvendelse av trombininhibitorer for inhibitering av okkular fibrindannelse
IL124883A0 (en) Amidino protease inhibitors and pharmaceutical compositions containing the same
NO983295D0 (no) Kontroll av helingsprosess
AU1023497A (en) Tissue factor - kunitz domain fusion proteins as factor viia inhibitors
DE69625505D1 (de) Guanidino proteiase inhibitoren
WO2002008222A3 (fr) Derives de heteroaryle-beta-alanine en tant qu'inhibiteurs d'alpha-4-integrine
CA2302720A1 (fr) Compositions sterilisantes avec anticoagulant et methodes connexes
EE04044B1 (et) Farmatseutilised tooted veresoonte endoteelirakkude kahjustuste tagajärjel tekkinud haiguste raviksja vältimiseks
NO306993B1 (no) Piperidinylmetyloksyzolidin-2-on-derivater, farmasoeytiske preparater som inneholder slike, samt anvendelse av forbindelsene til fremstilling av legemidler
AU9221898A (en) Pharmaceutical coating composition and method of use
TW340849B (en) Novel cyclopeptides and pharmaceutical compositions as integrin inhibitors comprizing the same
NO885472L (no) Fremgangsmaate for belegging av gjenstander av staal.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application